ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 6451 to 6473 of 99175 messages
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older
DateSubjectAuthorDiscuss
05/5/2020
19:26
GDR - what sales?Mugs pulled in on a high and getting stung!
dave444
05/5/2020
19:19
There was a placing and as you can see it still finished high.I would advise anyone not to buy the spike, just common sense.
countdracula55
05/5/2020
19:05
It is what happens on a hyped up stock that has sold little
dave444
05/5/2020
18:10
Those who bought GDR at 300 today only for it to halve within seconds may have a differing view to yours.
dovey21
05/5/2020
17:50
Thanks Count. I’m sure many of us are bothered
peachie 74
05/5/2020
17:48
If trials fail ?....HUGE RISK and not one I'm willing to take.Gdr is risk free and from here guaranteed profits.
countdracula55
05/5/2020
17:43
Batman's ears anyone?
volsung
05/5/2020
17:41
Late reported trades....2.7m....and counting.
Plenty from yesterday.

wetdream
05/5/2020
17:17
It's not bad! We're up 6p from Friday.
dovey21
05/5/2020
17:07
Just remember"Keep calm and save lives"Invest in SNG
svenice7
05/5/2020
17:07
I like Thursdays!!
vitec
05/5/2020
16:28
There better be massive after hrs trades to offset the buying we have seen throughout almost the entire day.Roll on Thursday.
cambradjones
05/5/2020
16:28
Blueblood Aye right. Been hearing that for a while now. Just trade it like everybody else.
russ42
05/5/2020
16:20
We will have news in May imo. Don't get caught out as you won't be getting back in this side of £1
blueblood
05/5/2020
16:20
People always say that to provoke a response. People are welcome to sell. But...if something pops out the blue yr locked out. Pays yr money takes yr chance.
idle jack
05/5/2020
16:16
expect the unexpected

hth

d1nga
05/5/2020
16:13
There is nothing expected that will move this share massively until the results are published - and that could be end of June ?

I suspect these will drift down now until end of May

equalibrium
05/5/2020
15:35
This is 'QI' Published yesterday



Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

5. Conclusion
The rapid diffusion of COVID-19 drives an urgent search for effective treatments, mainly for its severe forms. The disease is polyphasic in nature, with secondary cytokine storm and ARDS resulting in poor outcomes, plus overwhelmed intensive care units and hospitals. In the very early stages of the disease, treatment should focus on reducing viral load either by specific antivirals or by stimulating type-I IFN. Later on, in selected patients, therapies targeting proinflammatory cytokines could suppress hyperinflammation, while some cytokines (IL-7) could theoretically trigger immune restoration. In clinical practice, unfortunately, patients are unlikely to be detected early enough (i.e. before/at symptom onset) to benefit from antiviral strategies. Therefore, factors to predict progression toward severe forms of the disease are, at present, the most urgently needed and awaited determinants. A highly-structured approach, which includes immune monitoring, would thus be of utmost importance.

waterloo01
05/5/2020
14:33
Does it really matter if it goes back to 70p Because it will just get sold off back down to 63p.Until real news arrives its just a trader share .Then its only a matter of who sells first.Being truthful thats what i an going to do as well.Bought some at 63 and 65 so will Trade those but keep my main holding.
russ42
05/5/2020
14:33
Does it really matter if it goes back to 70p Because it will just get sold off back down to 63p.Until real news arrives its just a trader share .Then its only a matter of who sells first.Being truthful thats what i an going to do as well.Bought some at 63 and 65 so will Trade those but keep my main holding.
russ42
05/5/2020
14:31
Where is STRONG BUY ? I believe he was last seen on a rocket ???
141jaffa
05/5/2020
14:05
Don't start him off with another "WOW" brief!.. you won't get your milk at break time! ?
dovey21
05/5/2020
14:00
Waterloo it could come in 1? I am expecting it to drop any day.

Whites123- not quite sure I agree if they finished COPD trial which they are due to this summer alongside Covid trail and that proves positive there is scope for substantial upside.

crookie3634
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older